<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckely, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Bredella, Miriam</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">GH Replacement Improves CV Risk Factors in Viscerally Obese Premenopausal Women</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-12</style></pages><abstract><style  face="normal" font="default" size="100%">Effects of Growth Hormone on Body Composition and Cardiovascular Risk Markers in Women with Visceral Adiposity was a 6-month randomized, double-blind, placebo-controlled trial to determine whether low-dose GH administration would reduce abdominal adiposity and CV risk markers in premenopausal women with reduced GH secretion due to abdominal obesity.</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>